SUBSCRIBERS
Bayer Pharma continues to boost its presence in the Asia-Pacific
2015 regional revenue rises 7% to 4b euros; clinical trials triple in 9 years
Add BT as a preferred source
Nisha Ramchandani
Published Fri, Mar 18, 2016 · 09:50 PM
Singapore
The number of clinical trials conducted by Bayer Pharmaceuticals in Asia Pacific has more than tripled since 2007 - from 21 to 68 - as the healthcare group strengthens its focus on the region.
Here in Singapore, the number of trials has expanded nearly fourfold to 22 from six in the same time frame.
Copyright SPH Media. All rights reserved.
